Correction: Opportunities in somatostatin research: biological, chemical and therapeutic aspects

Nature Rev. Drug Discov. 2, 999–1017 (2003) (10.1038/nrd1255) A sentence on page 1007 of the article states: „Interestingly, contraction of this template to a heptapeptide, such as in TT-232 (compound 21), provides a somatostatin antagonist, the anti-inflammatory and antinociceptive effects of whichare possibly mediated by sst4”.